Clinical trial Recruiting at 1 site Interventional Ages 5 to 18

Team-delivered exposure-based CBT for children and teens with anxiety and OCD

Official title: Testing Delivery Modalities of Team-Based Cognitive Behavioral Treatment (CBT) for Pediatric Anxiety in Community Health Settings: Developing Pathways to Health Equity

Run by Bradley Hospital · NCT06934525 · Data updated 2026-11-12

This test tries three ways of delivering team-based exposure-focused CBT—in-person, by telehealth, or a flexible mix—to see which works best for kids and teens (ages 5–18) with anxiety or OCD.

More Anxiety trials

Quick facts

Study typeInterventional
Ages5 Years to 18 Years
SexAll
Enrollment501 (estimated)
SponsorBradley Hospital
Academic / other
Locations1 site (East Providence, Rhode Island)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedFebruary 1, 2029
Study endsAugust 1, 2029
Registry record updatedJuly 31, 2026
Trial IDNCT06934525 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are outpatients aged 5–18 with a primary or co-primary DSM-5 diagnosis of an anxiety disorder or OCD, symptoms for at least three months, and a stable parent or guardian who can participate in treatment.

Probably not a fit

Patients with an active primary psychiatric condition requiring other immediate treatment, acute suicidality, concurrent psychotherapy, unstable psychotropic medication, or medical issues that prevent active participation are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project compares three delivery methods of team-delivered, exposure-based cognitive behavioral therapy (CBT) for youth with anxiety disorders and OCD across Rhode Island. Children and adolescents (ages 5–18) receive weekly exposure-focused sessions with an exposure coach plus monthly visits with a licensed provider, delivered either in-person, entirely via telehealth, or via a flexible combination. The Hybrid Type 1 effectiveness-implementation design measures clinical outcomes while also examining contextual factors that affect adoption, sustainment, and scalability in community behavioral health centers and a federally qualified health center. The study partners with Certified Community Behavioral Health Centers and a Federally Qualified Health Center to improve equitable access for historically marginalized families.

Why it matters

Potential benefit: If successful, this approach could make effective exposure-based CBT more accessible across diverse communities and improve anxiety and OCD outcomes for children and teens.

How similar studies have gone: Exposure-based CBT is a well-established, evidence-based treatment for pediatric anxiety and OCD, and remote and team-delivered adaptations have growing supporting data, though large-scale statewide comparisons of delivery modalities are relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 5-18 inclusive
* Primary or co-primary DSM-V diagnosis of anxiety or OCD
* Symptom duration of at least 3 months
* Outpatient care needed
* Presence of a stable parent, or guardian, who can participate in treatment

Exclusion Criteria:

* Other primary or co-primary psychiatric disorder which requires initiation of other active current treatment
* Acute suicidality
* Concurrent psychotherapy
* Chronic medical illness that would preclude their active participation in treatment
* Treatment with psychotropic medication that is not stable

Where it's running

  • Bradley Hospital
    East Providence, Rhode Island, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.